Literature DB >> 6736638

A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.

N Masurel, J Laufer.   

Abstract

Three hundred volunteers were divided into two age groups, 14-30 years and 31-60 years. Each participant was immunized intramuscularly with a subunit, whole virus or absorbed whole virus vaccine, containing A/Bangkok/1/79 (H3N2), A/Brazil/11/78 (H1N1) and B/Singapore/222/79 influenza virus. Serum haemagglutination-inhibition (HI) antibody response, protection, and reactogenicity were studied after one and two doses of the vaccines. Primary immunization induced much higher percentages of HI antibody titres greater than or equal to 100 against all three vaccine viruses and much higher geometric mean titres (GMT) in volunteers with pre-immunization titres greater than or equal to 18 as compared to those with pre-immunization titres less than 18. Secondary immunization did not result in an increase of GMTs or antibody titres greater than or equal to 100 in volunteers with pre-immunization titres less than 18. On the whole, the response to the subunit vaccine was similar to that to the other two vaccines. To influenza B/Singapore/222/79 virus the response was lowest after administration of the whole virus vaccine in the age group 31-60 years. Over 50% of the HI titres greater than or equal to 100 found after immunization in the different vaccine and age groups were still present after one year. Serologically established infections during the winter months following immunization amounted to 15% in the subunit vaccine group, 6% in the whole virus vaccine group, and 10% in the adsorbed whole virus vaccine group. Local and systemic reactions to all three vaccines were mild in nature. Local reactions after primary immunization were much less frequent following administration of the subunit vaccine as compared to the other two vaccines, especially in the younger age group. In comparison to primary immunization, after booster immunization the incidence of local reactions was higher for the subunit vaccine and lower for the adsorbed whole virus vaccine. In the age group 14-30 years the incidence of local reactions after primary as well as booster immunization was much greater in females than in males, especially when the adsorbed whole virus vaccine was used.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736638      PMCID: PMC2129324          DOI: 10.1017/s0022172400064500

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  19 in total

1.  Adverse reactions after smallpox vaccination.

Authors:  B J Feery
Journal:  Med J Aust       Date:  1977-08-06       Impact factor: 7.738

2.  Antibody responses to influenza vaccines containing A/USSR/90/77.

Authors:  B J Feery; H A Gallichio; S J Rodda; A W Hampson
Journal:  Aust J Exp Biol Med Sci       Date:  1979-06

3.  Relation between Hong Kong virus and former human A2 isolates and the A-EQU12 virus in human sera collected before 1957.

Authors:  N Masurel
Journal:  Lancet       Date:  1969-05-03       Impact factor: 79.321

4.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

5.  Antibody response against current H1N1 influenza virus after vaccination with last season's trivanent vaccine.

Authors:  N Masurel; F E André
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

6.  [Influenza A during the Winter season 1977-78 caused by the "old" H3N2-virus and the "new" H1N1-virus].

Authors:  N Masurel; W J Anker
Journal:  Ned Tijdschr Geneeskd       Date:  1978-03-18

7.  Comparison of influenza B/Hong Kong virus infections among infants, children, and young adults.

Authors:  P F Wright; J D Bryant; D T Karzon
Journal:  J Infect Dis       Date:  1980-04       Impact factor: 5.226

8.  Field trial with human and equine influenza vaccines in children: protection and antibody titres.

Authors:  A Wesselius-de Casparis; N Masurel; K F Kerrebijn
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.

Authors:  C W Potter; R Jennings; K Nicholson; D A Tyrrell; K G Dickinson
Journal:  J Hyg (Lond)       Date:  1977-12

10.  Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain.

Authors:  N Masurel
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more
  13 in total

1.  Influenza update: a review of currently available vaccines.

Authors:  Lisa R Clayville
Journal:  P T       Date:  2011-10

2.  A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

Authors:  Laurent Coudeville; Philippe Andre; Fabrice Bailleux; Françoise Weber; Stanley Plotkin
Journal:  Hum Vaccin       Date:  2010-10-01

3.  Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.

Authors:  Iman Almansour; Huaiqing Chen; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2013-07-24       Impact factor: 3.452

4.  Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.

Authors:  W E Beyer; A M Palache; R Kerstens; N Masurel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 5.  Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome).

Authors:  S J Antony; D F Fleming; T K Bradley
Journal:  J Natl Med Assoc       Date:  1995-09       Impact factor: 1.798

6.  Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis.

Authors:  D J Versluis; W E Beyer; N Masurel; W Weimar; P Kramer; P P Diderich
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

Review 7.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

8.  Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus.

Authors:  R J Diepersloot; K P Bouter; W E Beyer; J B Hoekstra; N Masurel
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

9.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

10.  Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.

Authors:  W E Beyer; A M Palache; A D Osterhaus
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.